Matt Cave

3.0k total citations
28 papers, 2.2k citations indexed

About

Matt Cave is a scholar working on Epidemiology, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, Matt Cave has authored 28 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 9 papers in Physiology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Matt Cave's work include Liver Disease Diagnosis and Treatment (12 papers), Alcohol Consumption and Health Effects (7 papers) and Diet and metabolism studies (6 papers). Matt Cave is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Alcohol Consumption and Health Effects (7 papers) and Diet and metabolism studies (6 papers). Matt Cave collaborates with scholars based in United States, Australia and Russia. Matt Cave's co-authors include Craig J. McClain, K. Cameron Falkner, Banrida Wahlang, Guy Brock, Irina Kirpich, Shirish Barve, Ion V. Deaciuc, Savitri Appana, Heather B. Clair and Sidorov Pi and has published in prestigious journals such as The Science of The Total Environment, Hepatology and Environmental Health Perspectives.

In The Last Decade

Matt Cave

28 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matt Cave United States 18 1.1k 625 504 481 397 28 2.2k
Juliane I. Beier United States 26 870 0.8× 579 0.9× 245 0.5× 632 1.3× 268 0.7× 57 1.9k
Marcello Dallio Italy 29 1.6k 1.5× 903 1.4× 566 1.1× 340 0.7× 164 0.4× 98 3.2k
Karima Begriche France 23 1.5k 1.4× 724 1.2× 530 1.1× 265 0.6× 76 0.2× 36 2.6k
Nathan J. Cherrington United States 40 1.5k 1.4× 1.3k 2.1× 284 0.6× 253 0.5× 212 0.5× 118 4.7k
Fabrizia Carli Italy 17 1.0k 0.9× 487 0.8× 534 1.1× 101 0.2× 119 0.3× 38 1.8k
Halina Cichoż‐Lach Poland 18 659 0.6× 500 0.8× 217 0.4× 240 0.5× 91 0.2× 84 1.9k
Felipe Javier Chaves Spain 36 578 0.5× 1.3k 2.1× 757 1.5× 281 0.6× 430 1.1× 205 4.6k
Y. James Kang United States 20 520 0.5× 486 0.8× 183 0.4× 562 1.2× 287 0.7× 37 1.8k
Ignazio Grattagliano Italy 31 1.1k 1.0× 814 1.3× 573 1.1× 324 0.7× 70 0.2× 56 3.1k
O Karmin Canada 40 570 0.5× 1.3k 2.1× 534 1.1× 330 0.7× 79 0.2× 120 4.2k

Countries citing papers authored by Matt Cave

Since Specialization
Citations

This map shows the geographic impact of Matt Cave's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matt Cave with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matt Cave more than expected).

Fields of papers citing papers by Matt Cave

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matt Cave. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matt Cave. The network helps show where Matt Cave may publish in the future.

Co-authorship network of co-authors of Matt Cave

This figure shows the co-authorship network connecting the top 25 collaborators of Matt Cave. A scholar is included among the top collaborators of Matt Cave based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matt Cave. Matt Cave is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pavúk, Marián, et al.. (2019). Hypertension in Relation to Dioxins and Polychlorinated Biphenyls from the Anniston Community Health Survey Follow-Up. Environmental Health Perspectives. 127(12). 127007–127007. 17 indexed citations
3.
Liaquat, Hammad, et al.. (2018). Differences in Referral Access to Care Between Gastrointestinal Subspecialty Patients: Barriers and Opportunities. Health Equity. 2(1). 103–108. 3 indexed citations
4.
Frenette, Catherine, Giuseppe Morelli, Mitchell L. Shiffman, et al.. (2018). Emricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-Stage Liver Disease Scores Compared With Placebo. Clinical Gastroenterology and Hepatology. 17(4). 774–783.e4. 75 indexed citations
5.
Guardiola, John, Juliane I. Beier, K. Cameron Falkner, et al.. (2016). Occupational exposures at a polyvinyl chloride production facility are associated with significant changes to the plasma metabolome. Toxicology and Applied Pharmacology. 313. 47–56. 22 indexed citations
6.
Lang, Anna L., et al.. (2016). Role of dietary fatty acids in liver injury caused by vinyl chloride metabolites in mice. Toxicology and Applied Pharmacology. 311. 34–41. 25 indexed citations
7.
Wahlang, Banrida, K. Cameron Falkner, Matt Cave, & Russell A. Prough. (2015). Role of Cytochrome P450 Monooxygenase in Carcinogen and Chemotherapeutic Drug Metabolism. Advances in pharmacology. 74. 1–33. 31 indexed citations
8.
McClave, Stephen A., et al.. (2014). Treating Every Needle in the Haystack. Journal of Parenteral and Enteral Nutrition. 39(8). 977–985. 9 indexed citations
9.
Cave, Matt, et al.. (2014). Liver Diseases. World review of nutrition and dietetics. 111. 146–150. 5 indexed citations
10.
Cave, Matt, et al.. (2011). Serum Cytokeratin 18 and Cytokine Elevations Suggest A High Prevalence of Occupational Liver Disease in Highly Exposed Elastomer/Polymer Workers. Journal of Occupational and Environmental Medicine. 53(10). 1128–1133. 32 indexed citations
11.
McClave, Stephen A., Robert F. Kushner, Charles W. Van Way, et al.. (2011). Nutrition Therapy of the Severely Obese, Critically Ill Patient. Journal of Parenteral and Enteral Nutrition. 35(5S). 88S–96S. 51 indexed citations
12.
Hurt, Ryan T., Thomas H. Frazier, Stephen A. McClave, & Matt Cave. (2011). Pharmaconutrition for the Obese, Critically Ill Patient. Journal of Parenteral and Enteral Nutrition. 35(5S). 60S–72S. 12 indexed citations
13.
Cave, Matt, et al.. (2010). Polychlorinated Biphenyls, Lead, and Mercury Are Associated with Liver Disease in American Adults: NHANES 2003–2004. Environmental Health Perspectives. 118(12). 1735–1742. 235 indexed citations
14.
Frazier, Thomas H., et al.. (2010). Micronutrient-Related Neurologic Complications Following Bariatric Surgery. Current Gastroenterology Reports. 12(4). 288–295. 26 indexed citations
15.
Kirpich, Irina, Leila Gobejishvili, Sabine Waigel, et al.. (2010). Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease. The Journal of Nutritional Biochemistry. 22(1). 38–45. 138 indexed citations
16.
Cave, Matt, K. Cameron Falkner, Mukunda B. Ray, et al.. (2009). Toxicant-Associated Steatohepatitis in Vinyl Chloride Workers. Hepatology. 51(2). 474–481. 112 indexed citations
17.
Abdelmalek, Manal F., Schuyler O. Sanderson, Paul Angulo, et al.. (2009). Betaine for nonalcoholic fatty liver disease. Hepatology. 50(6). 1818–1826. 176 indexed citations
18.
Cave, Matt, Ryan T. Hurt, Thomas H. Frazier, et al.. (2008). Obesity, Inflammation, and the Potential Application of Pharmaconutrition. Nutrition in Clinical Practice. 23(1). 16–34. 139 indexed citations
19.
Kirpich, Irina, S. N. Leikhter, Sidorov Pi, et al.. (2008). Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol. 42(8). 675–682. 389 indexed citations
20.
Cave, Matt, et al.. (2007). Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition. The Journal of Nutritional Biochemistry. 18(3). 184–195. 231 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juliane I. Beier Breakdown of academic impact, for papers by Marcello Dallio Breakdown of academic impact, for papers by Karima Begriche Breakdown of academic impact, for papers by Nathan J. Cherrington Breakdown of academic impact, for papers by Fabrizia Carli Breakdown of academic impact, for papers by Halina Cichoż‐Lach Breakdown of academic impact, for papers by Felipe Javier Chaves Breakdown of academic impact, for papers by Y. James Kang Breakdown of academic impact, for papers by Ignazio Grattagliano Breakdown of academic impact, for papers by O Karmin
Rankless by CCL
2026